Trident Pharmaceuticals Obtains $275,187 New Financing

  • Feed Type
  • Date
    5/22/2014
  • Company Name
    Trident Pharmaceuticals
  • Mailing Address
    184 High Street Boston, MA 02110 USA
  • Company Description
    Trident Pharmaceuticals, founded in 2006, is dedicated to the development of novel immunomodulatory drug products for the treatment of inflammatory and autoimmune disorders and allergic conditions.
  • Website
    http://www.tridentpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $275,187
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

By posting a comment, you agree to our terms and conditions.